Expression levels of VEGF‑C and VEGFR‑3 in renal cell carcinoma and their association with lymph node metastasis-Reference-Cited by-同舟云学术

Expression levels of VEGF‑C and VEGFR‑3 in renal cell carcinoma and their association with lymph node metastasis

Published:2021-03-26 Issue:6 Volume:21 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Li Xiuming¹,Song Dianbin¹,Liu Hui²,Wang Zhiyong¹,Ma Guang¹,Yu Man¹,Zhang Yong³,Zeng Yu⁴

Affiliation:

1. Department of Urology, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei 067000, P.R. China

2. Key Laboratory of Ethnomedicine of Ministry of Education, Center on Translational Neuroscience, School of Pharmacy, Minzu University of China, Beijing 100081, P.R. China

3. Department of Pathology, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning 110042, P.R. China

4. Department of Urology, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning 110042, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dauricine Inhibits Non-small Cell Lung Cancer Development by Regulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in a FLT4-dependent Manner;Current Cancer Drug Targets;2024-11

2. Therapeutic options for different metastatic sites arising from renal cell carcinoma: A review;Medicine;2024-05-24

3. Long noncoding RNA BANCR promotes lymphangiogenesis and lymph node metastasis of pancreatic carcinoma by regulating VEGF-C/VEGFR-3 signaling pathway;2023-12-28

4. Predictive Value of VEGF-C and D Combined with Ultrasound Pathological Features for Nonsentinel Lymph Node Metastasis in SLN-Positive Early-Stage Breast Cancer;Clinical and Experimental Obstetrics & Gynecology;2023-09-27

5. Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy;Cancer Research Communications;2022-11-29